We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more
Ask ADVFN Intelligence (AI)
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024 NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...
Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Jade Biosciences...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.05 | 1.91570881226 | 2.61 | 2.715 | 2.52 | 411466 | 2.5927197 | CS |
| 4 | 0.44 | 19.8198198198 | 2.22 | 3 | 2.07 | 2040620 | 2.49350826 | CS |
| 12 | 0.78 | 41.4893617021 | 1.88 | 3 | 1.815 | 825087 | 2.41488834 | CS |
| 26 | -17.67 | -86.9158878505 | 20.33 | 25.285 | 1.25 | 956531 | 2.7523563 | CS |
| 52 | -11.59 | -81.3333333333 | 14.25 | 32.415 | 1.25 | 546950 | 4.99806504 | CS |
| 156 | -11.62 | -81.3725490196 | 14.28 | 32.415 | 1.25 | 239164 | 8.043929 | CS |
| 260 | -25.34 | -90.5 | 28 | 32.415 | 1.25 | 226978 | 8.70385724 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
